Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
about
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesisDistinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.American Joint Committee on Cancer prognostic factors consensus conference.Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options.Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response.BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.Tubal origin of ovarian low-grade serous carcinoma.Calretinin, CD34, and alpha-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary.Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problemsOvarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancerPrognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovaryDiverse tumorigenic pathways in ovarian serous carcinoma.Low-grade serous carcinomas of the ovary contain very few point mutationsFSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas.The molecular pathology of ovarian serous borderline tumors.Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.Invasive recurrence of serous borderline ovarian tumor as multifocal lymphadenopathy 25 years after initial diagnosis.Successful management of evisceration occurred after exploratory laparotomy for bilateral ovarian micropapillary serous borderline tumors.Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.Characterization and comparison of precursors of ovarian and endometrial carcinoma: parts I and II.Clinical management of borderline ovarian tumors.Ovarian epithelial tumors and reproductive factors: a systematic review.The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma.Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells.Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report.FGF18 as a potential biomarker in serous and mucinous ovarian tumors.Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.
P2860
Q26822545-FA216CBD-5621-43D6-8917-DB053A222ECDQ31141440-505740FE-FE34-4F9C-8A38-7D199A6B4E96Q33387074-8881B55E-E5B2-494E-8415-932231610ADEQ33789795-B572E5FB-DA0E-445A-9484-6E7B1C4890DFQ33894027-72E17114-00AB-484E-8D4E-1C2003E28D4BQ33953046-C982273B-94CD-4F20-A5E2-6E4F1EE10045Q34162272-E571F19E-8AAB-4714-AA50-781E2337770AQ34317865-2D9F4B95-3C33-433E-890C-21089A4947DDQ34383567-279A96C7-5E05-41A4-A580-33B57C8C4066Q34485039-013BCFA0-7788-467F-AA21-A1B6E7FE34A5Q34998994-077CA0D1-E5CA-4C5E-A3CE-1CB3F967B1E2Q35098091-DC0F842B-3D64-4020-AAA9-E02D30A1717BQ35140600-D5CF80FB-AFF9-4005-8774-476566A37A77Q35461505-54E2FE87-8BE7-4111-87D4-358D242C5F86Q35584451-D5740DB7-D753-452C-9795-D3CCFAC8B18CQ35789009-9A333274-F7F7-48E4-BD0E-2619DA2067C0Q36415602-07FD50FD-CF28-48BC-A2A5-598E5A0C937FQ36472462-96E1CECE-90ED-48D5-B6BD-5AAC2C653446Q36855249-3F9A23E0-892C-4B89-9EF4-45867114BB61Q37101060-8AEA8379-547F-4478-B941-B486835B8BA6Q37387606-53986017-EF6C-4C8B-BD01-5637EE44105AQ37560515-6315F9A2-E9B1-4488-8053-9E8917171309Q37632101-EBF00BCA-0075-464E-AAA5-A8D812DB1ED3Q37756401-59992E7A-8B62-4BDC-B756-249E7A769DD7Q37774358-3F732BD2-CEDD-4548-B905-73CE30A1C031Q38090489-F3045DA4-7E98-4630-8455-39D28F1EE214Q38096241-38DB89C9-6529-4810-9980-FE1AD0B35E62Q38167276-FF3F5CF3-C4F6-4C8A-AA26-B52491C651BFQ38679731-F3D64AF9-5D4F-45C3-B47F-EA86B48FE8CBQ39021052-CF6D4305-33DF-4ADB-998E-3DDD1BB66C8EQ40313322-85A96D47-4563-4943-87C2-0755E6B7D18BQ41114714-D82B31F3-A5F0-4F0C-9565-9CC11ADB7D84Q42995454-BFAE4872-C05E-407F-A068-431AAC4C3D89Q44800993-7CA9DAEE-EB0F-4A8D-8648-358341236156Q46496146-95670A5B-E865-4CE9-8DF3-D00ACC8E1B01Q46640081-86523096-6282-4E09-8EF6-5D10291004D2Q46711576-437968B0-5F06-40CC-B2EB-3D041E4A9D92Q47261959-EBFA55D9-BF31-4EDB-893E-3B15411B9EA7Q48268637-98286451-D56A-43B1-B235-C0445F564821Q49724000-8BE60410-9307-4DDD-8A9C-1165C65B782E
P2860
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Micropapillary serous carcinom ...... d to serous borderline tumors.
@en
Micropapillary serous carcinom ...... d to serous borderline tumors.
@nl
type
label
Micropapillary serous carcinom ...... d to serous borderline tumors.
@en
Micropapillary serous carcinom ...... d to serous borderline tumors.
@nl
prefLabel
Micropapillary serous carcinom ...... d to serous borderline tumors.
@en
Micropapillary serous carcinom ...... d to serous borderline tumors.
@nl
P2093
P1476
Micropapillary serous carcinom ...... d to serous borderline tumors.
@en
P2093
P304
P356
10.1097/00000478-199611000-00003
P407
P577
1996-11-01T00:00:00Z